About this trial
Patient Profile
Advanced or recurrent endometrial carcinoma
Where’s this trial being run?
Cork University Hospital and St James’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | ENGOT EN-9 |
|---|---|
| Number: | CTRIAL-IE 19-20 |
| Full Title: | A Phase 3 Randomized, Open Label Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK7902)Versus Chemotherapy for first line treatment of advanced or recurrent endometrial carcinoma |
| Principal Investigator: | Dearbhaile O'Donnell |
|---|---|
| Type: | Collaborative |
| Sponsor: | MSD |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | 720 |
|---|---|
| Ireland Recruitment Target: | 4 |